Quinoxaline 1,4-di-N-oxide and the Potential for Treating Tuberculosis

Quinoxaline 1,4-di-N-oxide and the Potential for Treating Tuberculosis

New drugs active against drug-resistant tuberculosis are urgently needed to extend the range of TB treatment options to cover drug resistant infections. Quinoxaline derivatives show very interesting biological properties (antibacterial, antiviral, anticancer, antifungal, antihelmintic, insecticidal)...

Full description

Bibliographic Details
Main Authors: Vicente, E. (Esther), Raquel, Pérez-Silanes, S. (Silvia), Aldana, I. (Ignacio), Goldman, R.C. (Robert C.), Monge, A. (Antonio), Solano, B. (Beatriz), Burguete, A. (Asunción), Ancizu, S. (Saioa), Zarranz, B. (Belén), Jaso, A. (Andrés), Marin, A. (Adoración)
Format: info:eu-repo/semantics/article
Language:eng
Published: Bentham Science Publishers 2011
Subjects:
Tuberculosis
Quinoxaline 1,4-di-N-oxide
Mycobacterium
Online Access:https://hdl.handle.net/10171/18728

Similar Items

Similar Items